Authors
Elena Elimova, MD, is an associate professor in the Department of Medicine at the University of Toronto, as well as a staff medical oncologist at Princess Margaret Hospital.
Sharon Hesterlee, PhD, is the chief research officer for the Muscular Dystrophy Association (MDA).
Advertisement
Advertisement
Trending on AJMC
1
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
2
MFN Drug Agreements Could Raise Prices Worldwide
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
5


